KJT Group Hires Director of Health Outcomes Research
KJT Group, Inc., a full service life sciences market research and insight consultancy firm, welcomes Arun Changolkar, PhD, MBA as the Director of Health Outcomes Research.
Honeoye Falls, NY, July 10, 2013 --(PR.com)-- KJT Group, Inc. is pleased to announce the hiring of Arun Changolkar, PhD, MBA as the Director of Health Outcomes Research to its expanding life sciences research and consulting organization.
Dr. Changolkar, of Philadelphia, brings extensive academic and professional experience in health economics and outcomes research. His experience includes leadership roles in the pharmaceutical and clinical research industries. With expertise in epidemiology and statistics his project experience spans both U.S. and global healthcare in oncology, vaccines, and autoimmune disease.
He joins KJT Group after serving in various industry positions including Director of Global Health Outcomes at Stiefel and Manager of Health Outcomes and Analytics at GlaxoSmithKline. His experience includes the design and execution of HEOR studies to support multiple global country specific successful reimbursement submissions, supporting clinical trials, and various other post-marketing observational studies to generate clinical evidence. He also participated in and contributed to strategic pricing, global value dossier synthesis, and core value development for various pharmaceutical products. Changolkar’s accomplishments include numerous abstracts in international and national scientific meetings and 11 publications in scientific journals.
“Arun brings a very nice mix of skills and experience to KJT Group’s growing Health Outcomes Practice. Having worked on both the client and vendor sides he brings strong analytic skills as well as a clear understanding of the underlying business issues that our customers face,” said Kenneth Tomaszewski, PhD, MS, Founder and CEO of KJT Group.
Following the completion of his PhD, Changolkar received post-doctoral training as an Anticancer Drug Discovery Researcher at Harvard Medical School and an Epigenetics Researcher at the University of Pennsylvania in Philadelphia.
As the Director of Health Outcomes Research at KJT Group, Changolkar will work closely with KJT Group researchers and oversee the design and conduct of KJT Group’s health economics and outcomes research studies.
About KJT Group: KJT Group is a full service life sciences market research and insight consultancy firm. Established in 2007, KJT Group employs nearly 50 full-time staff in New York, Pennsylvania, Texas, South Carolina and The Netherlands. KJT Group is a member of the National Council on Public Polls (NCPP), Council of American Survey Research Organizations (CASRO) and the European Society Opinion and Marketing Research (ESOMAR).
Press Contact:
Thomas M. Richardson, PhD
Chief Marketing Officer
KJT Group Inc.
6 East St.
Honeoye Falls, NY 14472
P 585.624.8050
tomr@kjtgroup.com
Dr. Changolkar, of Philadelphia, brings extensive academic and professional experience in health economics and outcomes research. His experience includes leadership roles in the pharmaceutical and clinical research industries. With expertise in epidemiology and statistics his project experience spans both U.S. and global healthcare in oncology, vaccines, and autoimmune disease.
He joins KJT Group after serving in various industry positions including Director of Global Health Outcomes at Stiefel and Manager of Health Outcomes and Analytics at GlaxoSmithKline. His experience includes the design and execution of HEOR studies to support multiple global country specific successful reimbursement submissions, supporting clinical trials, and various other post-marketing observational studies to generate clinical evidence. He also participated in and contributed to strategic pricing, global value dossier synthesis, and core value development for various pharmaceutical products. Changolkar’s accomplishments include numerous abstracts in international and national scientific meetings and 11 publications in scientific journals.
“Arun brings a very nice mix of skills and experience to KJT Group’s growing Health Outcomes Practice. Having worked on both the client and vendor sides he brings strong analytic skills as well as a clear understanding of the underlying business issues that our customers face,” said Kenneth Tomaszewski, PhD, MS, Founder and CEO of KJT Group.
Following the completion of his PhD, Changolkar received post-doctoral training as an Anticancer Drug Discovery Researcher at Harvard Medical School and an Epigenetics Researcher at the University of Pennsylvania in Philadelphia.
As the Director of Health Outcomes Research at KJT Group, Changolkar will work closely with KJT Group researchers and oversee the design and conduct of KJT Group’s health economics and outcomes research studies.
About KJT Group: KJT Group is a full service life sciences market research and insight consultancy firm. Established in 2007, KJT Group employs nearly 50 full-time staff in New York, Pennsylvania, Texas, South Carolina and The Netherlands. KJT Group is a member of the National Council on Public Polls (NCPP), Council of American Survey Research Organizations (CASRO) and the European Society Opinion and Marketing Research (ESOMAR).
Press Contact:
Thomas M. Richardson, PhD
Chief Marketing Officer
KJT Group Inc.
6 East St.
Honeoye Falls, NY 14472
P 585.624.8050
tomr@kjtgroup.com
Contact
KJT Group
Thomas Richardson
585 624 8050
www.kjtgroup.com
Thomas Richardson
585 624 8050
www.kjtgroup.com
Contact
Categories